Posts in tag

aspirin


Debbie Rigby rounds up the latest in research news Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose In this study analysis of individual …

Debbie Rigby takes a look at the latest in research news Cannabis for paediatric epilepsy: challenges and conundrums Evidence for its efficacy in treating epilepsy is limited but growing, with …

Debbie Rigby takes a look at the latest in research news Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations Onabotulinum toxin A (BoNT-A) is …

Debbie Rigby takes a look at the latest in research news  Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events A large cohort study of over 600,000 people aged 40 and …

Debbie Rigby rounds up the latest in research news  Pain as a disease: an overview This article analyses the notion of pain as a disease through an historical overview of …

Debbie Rigby takes a look at the latest in research news Role of Direct Oral Anticoagulants in the Management of Anticoagulation This article reviews the roles of dabigatran, rivaroxaban, apixaban, …

“As a HMR pharmacist I seem to spend a lot of time writing in the medications that are not on the referral. I also update the medical hx list as …

Debbie Rigby examines the latest research news Faecal microbiota transplantation for recurrent Clostridum difficile infection Faecal microbiota transplantation (FMT) has become routine in managing recurrent C. difficile infection (CDI) refractory …

Trial of daily aspirin use for disease prevention in older Australians will receive part of $483 million in grants for health and medical research announced by the Minister for Health …

Weekly Dose: aspirin, the pain and fever reliever that prevents heart attacks, strokes and maybe cancer Andrew Tonkin, Monash University Aspirin is, like ibuprofen and Voltaren (diclofenac), a non-steroidal anti-inflammatory …

Debbie Rigby takes a look at the latest research pertinent to community pharmacy Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes In this double-blind trial, liraglutide, an analogue of human …

Debbie Rigby presents the latest research news relevant to pharmacy Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease Evidence from a total of 11 trials involving more than 118,000 patients …